Physician Assistant · Chattanooga, TN
NPI
1154494383
Since 2006
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
979 E 3rd St Ste A550
Chattanooga, TN, 37403
Phone (423) 778-8224
Groups this clinician bills Medicare through
Medicare paid, 2024
$32K
1,043 services
Medicare patients, 2024
158
Average age 67
Drug cost, 2024
$3.3M
5,646 prescriptions
Company payments, 2025
$1,763
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tamara L Bennett was code 82962 (clinical chemistry), 293 times for 149 patients. In total Tamara L Bennett billed 1,043 services in 13 codes, and Medicare paid $32K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-12-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 82962 Clinical Chemistry | Office | 293 | 149 | $3.13 | $918 |
| 99214 Office E&M - Established | Office | 288 | 146 | $75.06 | $22K |
| 83036 Blood Count | Office | 231 | 138 | $9.32 | $2,152 |
| 95251 Test - Miscellaneous | Office | 165 | 88 | $21.71 | $3,583 |
| 99213 Office E&M - Established | Office | 20 | 19 | $51.79 | $1,036 |
By year: 2022 $40K for 1,441 services; 2023 $35K for 1,145 services; 2024 $32K for 1,043 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 293 | 149 | $3.13 | $918 |
| 83036 Blood Count | 231 | 138 | $9.32 | $2,152 |
Medicare prescription drug claims, 2024
In 2024, the drug Tamara L Bennett prescribed most often to Medicare patients was Ozempic (Semaglutide), with 592 prescriptions and refills. In total Tamara L Bennett wrote 5,646 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 592 | 805 | 114 | $759K |
| Jardiance Empagliflozin | 317 | 562 | 82 | $322K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 312 | 608 | 96 | $44K |
| Metformin Hcl Generic | 259 | 675 | 86 | $1,515 |
| Mounjaro Tirzepatide | 241 | 268 | 44 | $279K |
| Novolog Flexpen Insulin Aspart | 185 | 346 | 63 | $53K |
| Tresiba Flextouch U-200 Insulin Degludec | 176 | 307 | 43 | $204K |
| Farxiga Dapagliflozin Propanediol | 156 | 290 | 43 | $156K |
| Levothyroxine Sodium Generic | 153 | 382 | 51 | $926 |
| Tresiba Flextouch U-100 Insulin Degludec | 144 | 303 | 43 | $70K |
| Metformin Hcl Er Metformin Hcl | 139 | 379 | 43 | $1,031 |
| Trulicity Dulaglutide | 131 | 193 | 27 | $185K |
| Ultra-Fine Mini Pen Needle Pen Needle, Diabetic | 131 | 287 | 54 | $16K |
| Atorvastatin Calcium Generic | 124 | 351 | 50 | $1,298 |
| Humalog Kwikpen U-100 Insulin Lispro | 116 | 211 | 45 | $37K |
Brand drugs: 3,637 claims; generic drugs: 1,248 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tamara L Bennett $1,763 ($1,763 in general payments such as food, travel and fees) from 26 companies. The largest payer was Dexcom, Inc. with $186.
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. DXCM | 6 | $186 |
| Xeris Pharmaceuticals, Inc. | 3 | $173 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $167 |
| Insulet Corporation PODD | 13 | $158 |
| Intra-Sana Laboratories | 1 | $142 |
| Mannkind Corporation MNKD | 7 | $131 |
| CeQur Corporation | 1 | $126 |
| Novo Nordisk Inc NVO | 4 | $84.85 |
| Lilly USA, LLC LLY | 4 | $79.99 |
| Beta Bionics, Inc. BBNX | 3 | $66.35 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.